<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01796704</url>
  </required_header>
  <id_info>
    <org_study_id>COM120018CTIL</org_study_id>
    <nct_id>NCT01796704</nct_id>
  </id_info>
  <brief_title>Comparison of the Prediction Derived by the Cardiovascular Performance Reserve Index With the Clinical Evaluation</brief_title>
  <official_title>Comparison of the Prediction Derived by the Cardiovascular Performance Reserve Index (Calculated From Physiological Parameters) With the Clinical Evaluation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clalit Health Services</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Clalit Health Services</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study hypothesizes that an assumed cardiovascular performance reserve is physiologically&#xD;
      detectable.&#xD;
&#xD;
      High reserve at rest characterizes a healthy person while low reserve at rest characterizes&#xD;
      low functional capacity e.g. heart failure. The lower the reserve the severer the morbidity.&#xD;
&#xD;
      The reserve may be estimated through CVRI (cardiovascular reserve index) which is computed by&#xD;
      an algorithm composed of physiological measurements taken during the patient visit.&#xD;
&#xD;
      In this study the investigators evaluate CVRI capability in prediction of functional capacity&#xD;
      in comparison with the clinical evaluation during the same visit.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study hypothesizes that an assumed cardiovascular performance reserve is physiologically&#xD;
      detectable and continuously monitored by a physiological control (reserve control)not yet&#xD;
      discovered.&#xD;
&#xD;
      High reserve at rest characterizes a healthy person while low reserve at rest characterizes&#xD;
      low functional capacity e.g. heart failure. The lower the reserve the severer the morbidity.&#xD;
&#xD;
      The reserve is decreased reversibly with aerobic activity and may reach an exhaustion&#xD;
      threshold in which the assumed reserve control induces a reversible fatigue and dyspnea which&#xD;
      dissolve once the activity decreased.&#xD;
&#xD;
      The reserve may be estimated through CVRI (cardiovascular reserve index) which is computed by&#xD;
      an algorithm composed of physiological measurements taken during the patient visit (composed&#xD;
      of blood pressure, heart rate, respiratory rate, central venous pressure or its estimation,&#xD;
      weight, height and gender.&#xD;
&#xD;
      In this study the investigators evaluate CVRI capability in prediction of functional capacity&#xD;
      in comparison with the clinical evaluation during the same visit (cross sectional&#xD;
      comparison).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>cardiovascular reserve index</measure>
    <time_frame>1 day</time_frame>
    <description>CVRI</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Healthy</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>healthy and mild heart failure</arm_group_label>
    <description>diversity of patients</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The study population is composed of adults both genders:&#xD;
&#xD;
        healthy subjects visiting for administrative cause healthy subject during acute illness&#xD;
        patients with chronic conditions&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adult informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  an emergency case&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Uri Gabbay, M.D, M.P.H.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tel Aviv University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Independent physician Clinic Clalit Health Services</name>
      <address>
        <city>Tel Aviv</city>
        <zip>55900</zip>
        <country>Israel</country>
      </address>
    </facility>
    <contact>
      <last_name>Uri Gabbay, MD</last_name>
      <phone>+972-3-5343736</phone>
      <email>urigab@clalit.org.il</email>
    </contact>
    <contact_backup>
      <last_name>Merav Gabbay, MD</last_name>
      <phone>+972-3-5343736</phone>
      <email>meravgb@clalit.org.il</email>
    </contact_backup>
    <investigator>
      <last_name>Uri Gabbay, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <study_first_submitted>January 29, 2013</study_first_submitted>
  <study_first_submitted_qc>February 21, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 22, 2013</study_first_posted>
  <last_update_submitted>February 21, 2013</last_update_submitted>
  <last_update_submitted_qc>February 21, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 22, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>functional capacity</keyword>
  <keyword>NYHA class</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

